TBPH Operating Cash Flow (Statement)
Theravance Biopharma Inc · Operating Cash Flow (Statement)
TBPH Operating Cash Flow (Statement)
Latest reported$51.83Mperiod ending
TBPH Cash from Operations (-$83.43M → $51.83M)
Annual operating cash flow (statement)
High-resolution chart · PNG
TBPH operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 238,541,000 | |
| -11,535,000 | |
| -26,997,000 | |
| -186,991,000 | |
| -207,858,000 | |
| -250,403,000 | |
| -238,197,000 | |
| -112,867,000 | |
| -201,052,000 | |
| -98,989,000 | |
| -168,857,000 | |
| -175,155,000 | |
| -120,959,000 | |
| -119,107,000 | |
| -83,428,000 |